KKR & Co. Inc. Price Target Raised to $152 by Wells Fargo

KKR & Co. Inc. (NYSE:KKR) has recently seen its price target raised by analysts at Wells Fargo & Company, moving from $139.00 to $152.00, as reported on Friday. They have also maintained an “equal weight” rating on the stock. This new price objective indicates a potential upside of approximately 8.66% based on the company's current market price.

Furthermore, several other financial analysts have shared their insights on KKR. JMP Securities adjusted their price target from $135.00 to $150.00 and awarded the stock a “market outperform” rating in a report released on October 9th. Additionally, Redburn Atlantic initiated coverage of KKR with a “buy” rating and set a target price of $153.00. HSBC also began coverage on September 18th, giving KKR a “buy” rating and a price target of $148.00. Oppenheimer, on October 16th, raised its target price from $128.00 to $148.00 and also rated the stock as “outperform.” In contrast, StockNews.com recently upgraded KKR to a “sell” rating.

Analyst Ratings Overview

Based on the latest analysis, one research analyst has assigned KKR a sell rating, while two have rated it as hold. Conversely, twelve analysts have issued a buy rating, with two considering it a strong buy. Overall, data from MarketBeat.com reflects an average rating of "Moderate Buy" for KKR, with an average price target of $151.29.

Current Market Performance

As of Friday, KKR shares opened at $139.88. Over the past year, the stock has fluctuated between a low of $53.72 and a high of $147.15. The company commands a market capitalization of $124.14 billion, with a price-to-earnings (PE) ratio of 32.99. Other financial metrics include a price-to-earnings-growth (PEG) ratio of 1.20 and a beta of 1.62, indicating a moderate level of volatility.

Earnings Results

KKR reported its quarterly earnings on October 24th, showing an earnings per share (EPS) of $1.38, surpassing the consensus estimate of $1.03 by $0.35. The estimated revenue for this quarter was $1.23 billion, but KKR managed to generate $4.79 billion. The company's return on equity stands at 5.05%, with a net profit margin of 17.99%. When compared to the same quarter of the previous year, which had an EPS of $0.73, this performance indicates significant growth. Analysts anticipate that KKR will report an EPS of 3.97 for the current fiscal year.

Insider Transactions

In recent insider news, major shareholder Genetic Disorder L.P. sold 5.8 million shares of KKR on September 13th for approximately $149.35 million, at an average price of $25.75 per share. After this transaction, they retained about 25.26 million shares valued at approximately $650.47 million. In a related transaction, Kkr Group Partnership L.P. acquired 11.62 million shares on September 11th at an average price of $11.13 per share, totaling about $129.33 million. This acquisition brought their total holdings to approximately 92.96 million shares, worth about $1.03 billion. Insider ownership in KKR stands at around 39.34%.

Institutional Investment Activity

Recently, various hedge funds have adjusted their stakes in KKR. Versant Capital Management increased its holdings by 622.9% during the second quarter, now owning 253 shares valued at $27,000. Similarly, Mather Group raised its stake by 371.4%, holding 264 shares worth $27,000 after their recent purchases. Furthermore, ORG Wealth Partners established a new position in KKR during the third quarter valued at $31,000, while Raleigh Capital Management increased its position by 56.7%. Overall, institutional investors and hedge funds control approximately 76.26% of KKR's shares.

Company Overview

KKR & Co. Inc. operates as a private equity and real estate investment firm. They focus on a wide array of investment strategies including direct investments, fund of funds, acquisitions, leveraged buyouts, management buyouts, and more. Their expertise covers various stages of investing including credit special situations, growth equity, and distressed investments.

KKR, Stocks, Investment